Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2022

Open Access 01-12-2022 | Hemophilia | Research

Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh

Authors: Mohammed Nadimul Islam, Akhil Ranjon Biswas, Humayra Nazneen, Nobendu Chowdhury, Mahbubul Alam, Jayanta Banik, Md. Kamrul Hassan, Abdullah Az Zubayer Khan, Najmul Karim, Mohammad Jahid Hasan, Md. Abdullah Saeed Khan

Published in: Orphanet Journal of Rare Diseases | Issue 1/2022

Login to get access

Abstract

Background

Hemophilia is one of the commonest inherited bleeding disorders which may lead to chronic bleeding tendencies and life-long disabilities if not properly managed. Knowing the pattern of the disease aids in the prevention of disability and improvement of quality of life in hemophilia. However, there is a dearth of literature on the issue in Bangladesh. So, this study was designed to explore the frequency and site of spontaneous bleeding in moderate and severe hemophilia patients visiting in a tertiary level hospital.

Methods

This descriptive cross-sectional study was conducted at the department of Hematology and Bone Marrow Transplantation (BMT) Center in Dhaka Medical College Hospital, Dhaka between February 2020 and August 2020. A total of 44 diagnosed cases of moderate to severe hemophilia were included in the study according to inclusion criteria. A detailed inquiry of history, thorough physical examination and relevant investigations were done and were recorded in case-record form. Informed written consent was taken from patients or their guardians where appropriate. All procedures were done according to Declaration of Helsinki. After entry and checking, data was analysed using SPSS version 26.

Results

Out of 44 participants, 25 (56.8%) and 19 (43.2%) had moderate and severe hemophilia. Mean age of the study population was 21.31 (± 9.78) years with the majority aged between 11 and 20 years (45.5%). All sociodemographic features were similar across severity. Hemophilia A and B was found in 90.9% and 9.1%, respectively. However, all type B patients severe hemophilia making it statistically significantly different from type A (p = 0.029). The median age of first bleeding was 3.5 years and median age of first diagnosis was 5 years. Nevertheless, approximately 67.4% patients were diagnosed as a case of hemophilia at the time of their first diagnosis. The median spontaneous bleedings episodes among all patients was 32 (range: 0–97) which did not different significantly between severe and moderate patients. The most common affected (target) joint was knee joint (88.6%) followed by elbow joint (64%) among all patients. The knee joint was more commonly involved in severe than moderate disease.

Conclusion

This study observed the variations in pattern and frequency of spontaneous bleeding in patients with hemophilia. Severe disease was more frequent in hemophilia B than A and knee joint was the most frequent site of bleeding. However, further extensive studies are recommended.
Literature
1.
go back to reference Karim MA, Jamal CY. A review on hemophilia in children. Bangladesh J Child Health. 2013;37(1):27–40.CrossRef Karim MA, Jamal CY. A review on hemophilia in children. Bangladesh J Child Health. 2013;37(1):27–40.CrossRef
2.
go back to reference Mannucci PM, Tuddenham EGD. The hemophilias — from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773–9.CrossRef Mannucci PM, Tuddenham EGD. The hemophilias — from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773–9.CrossRef
3.
go back to reference Payal V, Sharma P, Goyal V, Jora R, Parakh M, Payal D. Clinical profile of hemophilia patients in Jodhpur Region. Asian J Transfus Sci. 2016;10(1):101–4.CrossRef Payal V, Sharma P, Goyal V, Jora R, Parakh M, Payal D. Clinical profile of hemophilia patients in Jodhpur Region. Asian J Transfus Sci. 2016;10(1):101–4.CrossRef
4.
go back to reference Santagostino E, Mannucci PM, Bonomi AB. Guidelines on replacement therapy for hemophilia and inherited coagulation disorders in Italy. Hemophilia. 2000;6(1):1–10.CrossRef Santagostino E, Mannucci PM, Bonomi AB. Guidelines on replacement therapy for hemophilia and inherited coagulation disorders in Italy. Hemophilia. 2000;6(1):1–10.CrossRef
5.
go back to reference World Federation Of Hemophilia Global Survey Report 2018. 2019. World Federation Of Hemophilia Global Survey Report 2018. 2019.
6.
go back to reference Coppola A. Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med. 2010;183:66. Coppola A. Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med. 2010;183:66.
7.
go back to reference van Dijk K, Fischer K, van der Bom JG, Grobbee DE, van den Berg HM. Variability in clinical phenotype of severe hemophilia: the role of the first joint bleed. Hemophilia. 2005;11(5):438–43.CrossRef van Dijk K, Fischer K, van der Bom JG, Grobbee DE, van den Berg HM. Variability in clinical phenotype of severe hemophilia: the role of the first joint bleed. Hemophilia. 2005;11(5):438–43.CrossRef
8.
go back to reference Zimmerman B, Valentino LA. Hemophilia: in review. Pediatr Rev. 2013;34(7):289–95.CrossRef Zimmerman B, Valentino LA. Hemophilia: in review. Pediatr Rev. 2013;34(7):289–95.CrossRef
9.
10.
go back to reference Aznar JA, Lucía F, Abad-Franch L, Jiménez-Yuste V, Pérez R, Batlle J, et al. Hemophilia in Spain. Hemophilia. 2009;15(3):665–75.CrossRef Aznar JA, Lucía F, Abad-Franch L, Jiménez-Yuste V, Pérez R, Batlle J, et al. Hemophilia in Spain. Hemophilia. 2009;15(3):665–75.CrossRef
11.
go back to reference Molho R, Lebrun D, Courpied C, et al. Epidemiological survey of the orthopaedic status of severe hemophilia A and B patients in France. Hemophilia. 2000;6(1):23–32.CrossRef Molho R, Lebrun D, Courpied C, et al. Epidemiological survey of the orthopaedic status of severe hemophilia A and B patients in France. Hemophilia. 2000;6(1):23–32.CrossRef
12.
go back to reference Dauty M, Sigaud M, Trossaërt M, Fressinaud E, Letenneur J, Dubois C. Iliopsoas hematoma in patients with hemophilia: a single-center study. Jt Bone Spine. 2007;74(2):179–83.CrossRef Dauty M, Sigaud M, Trossaërt M, Fressinaud E, Letenneur J, Dubois C. Iliopsoas hematoma in patients with hemophilia: a single-center study. Jt Bone Spine. 2007;74(2):179–83.CrossRef
13.
go back to reference Poonnoose PM, Manigandan C, Thomas R, et al. Functional Independence Score in Haemophilia: a new performance-based instrument to measure disability. Haemophilia. 2005;11:598–602.CrossRef Poonnoose PM, Manigandan C, Thomas R, et al. Functional Independence Score in Haemophilia: a new performance-based instrument to measure disability. Haemophilia. 2005;11:598–602.CrossRef
14.
go back to reference Saha M, Ullah S, Mondal D, Bakar M, Bhuiyan J. Hemophilia: an Update. J Bangladesh Coll Physicians Surg. 2007;25(1):29–37.CrossRef Saha M, Ullah S, Mondal D, Bakar M, Bhuiyan J. Hemophilia: an Update. J Bangladesh Coll Physicians Surg. 2007;25(1):29–37.CrossRef
16.
go back to reference Singh J, Chaudhary A, Yadav S, Singh D, Pal R, Sibia S. Clinico-epidemiological profile of hemophilia patients in north India: an observational study. IOSR J Dent Med Sci. 2019;18(1):10–5. Singh J, Chaudhary A, Yadav S, Singh D, Pal R, Sibia S. Clinico-epidemiological profile of hemophilia patients in north India: an observational study. IOSR J Dent Med Sci. 2019;18(1):10–5.
17.
go back to reference John JM, Tanuja T, Mathew A, Philip CC, Sings J, Dinakaran M, et al. Demographic profile and real world data of persons with hemophilia in a resource constrained setup. Chrismed J Heal Res. 2014;1(2):2–4. John JM, Tanuja T, Mathew A, Philip CC, Sings J, Dinakaran M, et al. Demographic profile and real world data of persons with hemophilia in a resource constrained setup. Chrismed J Heal Res. 2014;1(2):2–4.
19.
go back to reference Minhas HL, Giangrande PL. Presentation of severe haemophilia—a role for accident and emergency doctors? Emerg Med J. 2001;18(4):246–9.CrossRef Minhas HL, Giangrande PL. Presentation of severe haemophilia—a role for accident and emergency doctors? Emerg Med J. 2001;18(4):246–9.CrossRef
20.
go back to reference Kadhim KAR, Al-Lami FH, Baldawi KH. Epidemiological profile of hemophilia in Baghdad-Iraq. Inq J Heal Care Organ Provis Financ. 2019;56:004695801984528. Kadhim KAR, Al-Lami FH, Baldawi KH. Epidemiological profile of hemophilia in Baghdad-Iraq. Inq J Heal Care Organ Provis Financ. 2019;56:004695801984528.
21.
go back to reference Franchini M, Mannucci PM. Hemophilia B is clinically less severe than hemophilia A: further evidence. Blood Transfus. 2018;16(2):121–2.PubMedPubMedCentral Franchini M, Mannucci PM. Hemophilia B is clinically less severe than hemophilia A: further evidence. Blood Transfus. 2018;16(2):121–2.PubMedPubMedCentral
23.
go back to reference Qasim Z, Asif N, Hassan K. Pattern of bleeding in haemophilia patients. J Islam Med Dent Coll. 2014;3:3–6. Qasim Z, Asif N, Hassan K. Pattern of bleeding in haemophilia patients. J Islam Med Dent Coll. 2014;3:3–6.
24.
go back to reference Ghosh K, Ghosh K. Management of haemophilia in developing countries: challenges and options. Indian J Hematol Blood Transfus. 2016;32:347–55.CrossRef Ghosh K, Ghosh K. Management of haemophilia in developing countries: challenges and options. Indian J Hematol Blood Transfus. 2016;32:347–55.CrossRef
25.
go back to reference Mishra S, Kumar S, Panwar A, et al. A clinical profile of hemophilia patients and assessment of their quality of life in Western Uttar Pradesh, India: an observational study. Med J Dr DY Patil Univ. 2016;9:320.CrossRef Mishra S, Kumar S, Panwar A, et al. A clinical profile of hemophilia patients and assessment of their quality of life in Western Uttar Pradesh, India: an observational study. Med J Dr DY Patil Univ. 2016;9:320.CrossRef
26.
go back to reference Graf L, Yan S, Shen M-C, et al. A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A. J Med Econ. 2020;23:1493–8.CrossRef Graf L, Yan S, Shen M-C, et al. A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A. J Med Econ. 2020;23:1493–8.CrossRef
27.
go back to reference Ay C, Perschy L, Rejtö J, et al. Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting. Ann Hematol. 2020;99:2763–71.CrossRef Ay C, Perschy L, Rejtö J, et al. Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting. Ann Hematol. 2020;99:2763–71.CrossRef
28.
go back to reference Franchini M, Mannucci P. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012;7:24.CrossRef Franchini M, Mannucci P. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012;7:24.CrossRef
Metadata
Title
Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh
Authors
Mohammed Nadimul Islam
Akhil Ranjon Biswas
Humayra Nazneen
Nobendu Chowdhury
Mahbubul Alam
Jayanta Banik
Md. Kamrul Hassan
Abdullah Az Zubayer Khan
Najmul Karim
Mohammad Jahid Hasan
Md. Abdullah Saeed Khan
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Hemophilia
Published in
Orphanet Journal of Rare Diseases / Issue 1/2022
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-022-02413-7

Other articles of this Issue 1/2022

Orphanet Journal of Rare Diseases 1/2022 Go to the issue